Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sothiny Sar"'
Autor:
Marie Y. Detrait, Stephane Morisset, Sabine Cohen, Monique Manchon, Verane Schwiertz, Florence Ranchon, Nicolas Vantard, Caroline Serrier, Adrien Quintela, Christiane Cazac, Carole Hospital, Valerie Chapel, Sothiny Sar, Catherine Rioufol, Mauricette Michallet, Fiorenza Barraco
Publikováno v:
Blood. 122:4549-4549
Introduction Tacrolimus is a widely used calcineurin inhibitor in allogeneic HCST for prophylaxis and treatment of GvHD. This molecule is now available in both standard-release (Prograf, twice-daily tacrolimus, Astellas Pharma) and extended-release (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86806374441302822f77d7cd79e90440
https://doi.org/10.1182/blood.v122.21.4549.4549
https://doi.org/10.1182/blood.v122.21.4549.4549
Autor:
Sothiny Sar, Mauricette Michallet, Sophie Ducastelle, Franck E. Nicolini, Isabelle Tigaud, Nathalie Tedone, Hélène Labussière-Wallet, Catherine Rioufol, Stephane Morisset, Jean-Pierre Magaud, Sandrine Hayette, Mohamad Sobh, Xavier Thomas, Adrien Quintela, Marie Y. Detrait, Fiorenza Barraco, Vérane Schwiertz, Valérie Chapelle, Florence Ranchon, Youcef Chelghoum
Publikováno v:
Blood. 120:4549-4549
Abstract 4549 Introduction Patients with high risk AML have poor outcomes. However, the only approach with curative potential remains allogeneic HSCT. With the aim to improve the effect of allogeneic HSCT by sequential use of chemotherapy, RIC regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98e3f05810199f6a9a6a0c6b71c4fe3c
https://doi.org/10.1182/blood.v120.21.4549.4549
https://doi.org/10.1182/blood.v120.21.4549.4549
Autor:
Youcef Chelghoum, Marie Y. Detrait, Franck E. Nicolini, Valérie Chapelle, Hélène Labussière-Wallet, Sothiny Sar, Jean-Paul Bourgeot, Stephane Morisset, Fiorenza Barraco, Mohamad Sobh, Olivier Hequet, Valérie Mialou, Xavier Thomas, Mauricette Michallet, Sophie Ducastelle, Yves Bertrand, Valérie Dubois
Publikováno v:
Blood. 120:1992-1992
Abstract 1992 Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for many hematological malignancies for which umbilical cord blood (UCB) represents an alternative source of HSC. In order to overcome the low cellularity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::258ddeede1f5f0864622d9eaaff73aad
https://doi.org/10.1182/blood.v120.21.1992.1992
https://doi.org/10.1182/blood.v120.21.1992.1992